Difference between revisions of "Actinium Ac 225 lintuzumab (Actimab-A)"
Jump to navigation
Jump to search
m |
m |
||
| Line 11: | Line 11: | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
| − | + | [[Category:Radioimmunoconjugate]] | |
[[Category:Radiotherapy medications]] | [[Category:Radiotherapy medications]] | ||
[[Category:Anti-CD33 antibodies]] | [[Category:Anti-CD33 antibodies]] | ||
Revision as of 13:21, 13 March 2021
Mechanism of action
Monoclonal antibody directed against CD33 with a radioactive agent attached.
Preliminary data
Acute myeloid leukemia
Also know as
- Brand name: Actimab-A